WARREN – September 26, 2013 - McKeon Products, Inc. is proud to introduce the new Airmax™ Nasal Device. The Airmax™ Nasal Device is a clinically proven endonasal (inside the nasal passage) medical device that increases airflow through the nose, providing a simple and effective solution for individuals who have difficulties breathing while sleeping or as a result of colds and allergies.
The Airmax™ Nasal Device is different from other nasal devices on the market, as it expands the narrowest parts of the nasal channel allowing maximum airflow. Multiple clinical studies have proven its effectiveness in improving airflow, reducing snoring, and reducing mild sleep apnea. Additionally, the results of a recent study show that consumers preferred the Airmax™ over other nasal device alternatives.
The Airmax™ Nasal Device is important in helping consumers address nasal breathing difficulties and sleep challenges. The negative effects of habitual snoring can put people at risk for serious health problems, including obstructive sleep apnea, which can also put undue strain on the heart. In general, lack of quality sleep can lead to drowsiness during the day and can interfere with quality of life.
McKeon Products, Inc.